WFOT

Paulo Peregrino's CAR-T Remission Offered Hope After Years of Cancer Treatment

Paulo Peregrino entered complete remission after CAR-T treatment in Brazil in 2023. His case shows promise without proving a permanent cure.

An entrance to Hospital das Clínicas in São Paulo; a location photograph, not Paulo Peregrino's treatment.
An entrance to Hospital das Clínicas in São Paulo; a location photograph, not Paulo Peregrino's treatment. Photo: Maxpana3 / CC BY-SA 4.0. Resized.

After years of cancer treatment, Paulo Peregrino received a result he had long hoped to hear: his lymphoma was in complete remission. In 2023, the Brazilian patient's response to CAR-T therapy brought attention to a treatment built from immune cells.

The result was remarkable. It was also important to describe it precisely: remission is a treatment outcome, not proof that cancer can never return.

A long medical history

In a first-person diary published by piauí, Peregrino described 13 years of cancer care, including chemotherapy and a bone-marrow transplant. He was 61 when his CAR-T story became widely reported.

The history involved more than a single cancer diagnosis. Calling it 13 uninterrupted years with the same lymphoma would oversimplify that record.

An entrance to Hospital das Clínicas in São Paulo; a location photograph, not Paulo Peregrino's treatment.
An entrance to Hospital das Clínicas in São Paulo; a location photograph, not Paulo Peregrino's treatment. Photo: Maxpana3 / CC BY-SA 4.0. Resized.

Turning immune cells into a treatment

CAR-T therapy modifies T cells, a type of immune cell, so they can recognize a target on cancer cells. The altered cells are then given back to the patient.

The U.S. National Cancer Institute explains the process, along with the successes and challenges of this approach. It is a specialized treatment whose benefits and risks depend on the disease, treatment and individual patient.

The outpatient building at Hospital das Clínicas, photographed in 2013; an institutional view.
The outpatient building at Hospital das Clínicas, photographed in 2013; an institutional view. Photo: Andréatl / CC BY-SA 3.0. Resized.

Why the Brazilian case mattered

University of São Paulo reporting preserved by its Cell Therapy Center described Peregrino's access through a research collaboration involving university teams, the Butantan Institute and the blood center. His case drew attention to expanding access to advanced cellular therapies.

A powerful individual response cannot predict what will happen to every patient. Long-term follow-up, careful selection and specialist monitoring remain part of the story.

Peregrino's experience is hopeful because it shows a real medical possibility after earlier treatment had not brought the outcome he needed. The strongest account keeps both parts together: the extraordinary relief of remission and the continuing work required to understand and deliver that benefit.

Photograph credits

Be the first to react

Most read today

  1. Explore AmericaBorn Without Arms or Legs, He Raised Two Daughters With His Mother's Help. Years Later, His Daughter Came Home for Him.~3.2k reads today
  2. Beyond the SpotlightWhat Happened to Yanni The Quiet Life of Yiannis Chryssomallis After Fame~3.1k reads today
  3. Explore AmericaA Newborn Baby Appeared to Have a Full Moustache. The Viral Video Has People Asking If It's Real.~3k reads today
  4. Trending News115 Workers Were Aboard an Oil Rig When It Sank Off Gabon. Five Are Still Unaccounted For.~3k reads today
  5. Explore AmericaHe Ate at the Same Restaurant for 10 Years. When He Stopped Showing Up, a Chef Saved His Life.~3k reads today
  6. Celeb NewsRFK's Granddaughter Kyle Kennedy Dies at 42 After a Life Devoted to Education and Advocacy~2.8k reads today
  7. Trending NewsFlight Attendant Helps Exhausted Mom and Baby in Moment Captured by Fellow Passenger~2.7k reads today
  8. Trending NewsPresley Gerber Video Reportedly Shows Night Before His Death at Santa Monica Rehab~2.6k reads today